array(40) {
  [0]=>
  string(4) "9128"
  ["article_id"]=>
  string(4) "9128"
  [1]=>
  string(64) "FDA Sees No Evidence of Suicidal Ideation in Diabetes/Diet Drugs"
  ["article_title"]=>
  string(64) "FDA Sees No Evidence of Suicidal Ideation in Diabetes/Diet Drugs"
  [2]=>
  string(153) "&#nl        After evaluating reports of suicidal thoughts or action in patients taking diabetes and weight loss drugs containing glucagon-like peptide 1 "
  ["short_description"]=>
  string(153) "&#nl        After evaluating reports of suicidal thoughts or action in patients taking diabetes and weight loss drugs containing glucagon-like peptide 1 "
  [3]=>
  string(334) "&#nl        After evaluating reports of suicidal thoughts or action in patients taking diabetes and weight loss drugs containing glucagon-like peptide 1 receptor agonists (GLP-1 RA) such as Ozempic/Wegovy, Byetta, Trulicity and Rybelsus, the FDA says its preliminary evaluation has found no evidence of these adverse events.&#nl      "
  ["description"]=>
  string(334) "&#nl        After evaluating reports of suicidal thoughts or action in patients taking diabetes and weight loss drugs containing glucagon-like peptide 1 receptor agonists (GLP-1 RA) such as Ozempic/Wegovy, Byetta, Trulicity and Rybelsus, the FDA says its preliminary evaluation has found no evidence of these adverse events.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(104) "https://www.fdanews.com/articles/213112-fda-sees-no-evidence-of-suicidal-ideation-in-diabetes-diet-drugs"
  ["blog_url"]=>
  string(104) "https://www.fdanews.com/articles/213112-fda-sees-no-evidence-of-suicidal-ideation-in-diabetes-diet-drugs"
  [15]=>
  string(19) "2024-01-13 04:50:28"
  ["add_date"]=>
  string(19) "2024-01-13 04:50:28"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:51"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:51"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9129"
  ["article_id"]=>
  string(4) "9129"
  [1]=>
  string(47) "Regulatory Update — Week of Jan. 8, 2024"
  ["article_title"]=>
  string(47) "Regulatory Update — Week of Jan. 8, 2024"
  [2]=>
  string(153) "&#nl        Over the past week, the FDA issued a final guidance viral safety evaluation of biotechnology product derived from human or animal cells and d"
  ["short_description"]=>
  string(153) "&#nl        Over the past week, the FDA issued a final guidance viral safety evaluation of biotechnology product derived from human or animal cells and d"
  [3]=>
  string(299) "&#nl        Over the past week, the FDA issued a final guidance viral safety evaluation of biotechnology product derived from human or animal cells and draft guidance on sterility information in 510(k) premarket notifications and requests for reconsideration of division level under GDUFA.&#nl      "
  ["description"]=>
  string(299) "&#nl        Over the past week, the FDA issued a final guidance viral safety evaluation of biotechnology product derived from human or animal cells and draft guidance on sterility information in 510(k) premarket notifications and requests for reconsideration of division level under GDUFA.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(76) "https://www.fdanews.com/articles/213114-regulatory-update-week-of-jan-8-2024"
  ["blog_url"]=>
  string(76) "https://www.fdanews.com/articles/213114-regulatory-update-week-of-jan-8-2024"
  [15]=>
  string(19) "2024-01-13 04:40:04"
  ["add_date"]=>
  string(19) "2024-01-13 04:40:04"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:51"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:51"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9130"
  ["article_id"]=>
  string(4) "9130"
  [1]=>
  string(77) "UK Regulatory Agency Announces Roadmap for New Medical Technology Regulations"
  ["article_title"]=>
  string(77) "UK Regulatory Agency Announces Roadmap for New Medical Technology Regulations"
  [2]=>
  string(153) "&#nl        The UK Medicines and Healthcare products Regulatory Agency (MHRA) has laid out the final roadmap for 2024 to create a comprehensive set of re"
  ["short_description"]=>
  string(153) "&#nl        The UK Medicines and Healthcare products Regulatory Agency (MHRA) has laid out the final roadmap for 2024 to create a comprehensive set of re"
  [3]=>
  string(301) "&#nl        The UK Medicines and Healthcare products Regulatory Agency (MHRA) has laid out the final roadmap for 2024 to create a comprehensive set of regulations for medical devices and technology, bringing the UK one step closer to finalizing its regulatory framework after leaving the EU.&#nl      "
  ["description"]=>
  string(301) "&#nl        The UK Medicines and Healthcare products Regulatory Agency (MHRA) has laid out the final roadmap for 2024 to create a comprehensive set of regulations for medical devices and technology, bringing the UK one step closer to finalizing its regulatory framework after leaving the EU.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(117) "https://www.fdanews.com/articles/213113-uk-regulatory-agency-announces-roadmap-for-new-medical-technology-regulations"
  ["blog_url"]=>
  string(117) "https://www.fdanews.com/articles/213113-uk-regulatory-agency-announces-roadmap-for-new-medical-technology-regulations"
  [15]=>
  string(19) "2024-01-13 04:30:46"
  ["add_date"]=>
  string(19) "2024-01-13 04:30:46"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:51"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:51"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9232"
  ["article_id"]=>
  string(4) "9232"
  [1]=>
  string(75) "How integrating AI and clinical decision support systems can help in the ER"
  ["article_title"]=>
  string(75) "How integrating AI and clinical decision support systems can help in the ER"
  [2]=>
  string(150) "A Yale University School of Medicine ER clinical informatics expert offers a deep dive preview of his HIMSS24 educational session that will show how a"
  ["short_description"]=>
  string(150) "A Yale University School of Medicine ER clinical informatics expert offers a deep dive preview of his HIMSS24 educational session that will show how a"
  [3]=>
  string(210) "A Yale University School of Medicine ER clinical informatics expert offers a deep dive preview of his HIMSS24 educational session that will show how artificial intelligence and CDS can boost emergency care.&#nl"
  ["description"]=>
  string(210) "A Yale University School of Medicine ER clinical informatics expert offers a deep dive preview of his HIMSS24 educational session that will show how artificial intelligence and CDS can boost emergency care.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(106) "https://www.healthcareitnews.com/news/how-integrating-ai-and-clinical-decision-support-systems-can-help-er"
  ["blog_url"]=>
  string(106) "https://www.healthcareitnews.com/news/how-integrating-ai-and-clinical-decision-support-systems-can-help-er"
  [15]=>
  string(19) "2024-01-13 00:38:02"
  ["add_date"]=>
  string(19) "2024-01-13 00:38:02"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:53"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9233"
  ["article_id"]=>
  string(4) "9233"
  [1]=>
  string(80) "HIMSSCast: How Karmanos Cancer Institute uses AI to find high-risk breast cancer"
  ["article_title"]=>
  string(80) "HIMSSCast: How Karmanos Cancer Institute uses AI to find high-risk breast cancer"
  [2]=>
  string(158) ""Finding out the patient is high-risk after they are diagnosed with cancer is too late," says Dr. Eric Brown, surgical oncologist and breast multidisc"
  ["short_description"]=>
  string(158) ""Finding out the patient is high-risk after they are diagnosed with cancer is too late," says Dr. Eric Brown, surgical oncologist and breast multidisc"
  [3]=>
  string(184) ""Finding out the patient is high-risk after they are diagnosed with cancer is too late," says Dr. Eric Brown, surgical oncologist and breast multidisciplinary team co-lead.&#nl"
  ["description"]=>
  string(184) ""Finding out the patient is high-risk after they are diagnosed with cancer is too late," says Dr. Eric Brown, surgical oncologist and breast multidisciplinary team co-lead.&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(114) "https://www.healthcareitnews.com/news/himsscast-how-karmanos-cancer-institute-uses-ai-find-high-risk-breast-cancer"
  ["blog_url"]=>
  string(114) "https://www.healthcareitnews.com/news/himsscast-how-karmanos-cancer-institute-uses-ai-find-high-risk-breast-cancer"
  [15]=>
  string(19) "2024-01-12 23:07:41"
  ["add_date"]=>
  string(19) "2024-01-12 23:07:41"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:53"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9216"
  ["article_id"]=>
  string(4) "9216"
  [1]=>
  string(55) "Talent Assessment: How AI Opens Careers to Young People"
  ["article_title"]=>
  string(55) "Talent Assessment: How AI Opens Careers to Young People"
  [2]=>
  string(150) "In an era defined by rapidly evolving technologies and industries, young people face a daunting task. How can they find the best job opportunities in "
  ["short_description"]=>
  string(150) "In an era defined by rapidly evolving technologies and industries, young people face a daunting task. How can they find the best job opportunities in "
  [3]=>
  string(676) "
In an era defined by rapidly evolving technologies and industries, young people face a daunting task. How can they find the best job opportunities in a massive sea of possibilities? Traditionally, the recruiting process matched candidate qualifications with general company profiles. But that’s no longer sufficient for candidates or hiring companies. Instead, employers are embracing […]
&#nl
The post Talent Assessment: How AI Opens Careers to Young People appeared first on TalentCulture.
&#nl"
  ["description"]=>
  string(676) "
In an era defined by rapidly evolving technologies and industries, young people face a daunting task. How can they find the best job opportunities in a massive sea of possibilities? Traditionally, the recruiting process matched candidate qualifications with general company profiles. But that’s no longer sufficient for candidates or hiring companies. Instead, employers are embracing […]
&#nl
The post Talent Assessment: How AI Opens Careers to Young People appeared first on TalentCulture.
&#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "4"
  ["category"]=>
  string(1) "4"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "55"
  ["rss_id"]=>
  string(2) "55"
  [14]=>
  string(184) "https://talentculture.com/blog/talent-assessment-how-ai-opens-careers-to-young-people/?utm_source=rss&utm_medium=rss&utm_campaign=talent-assessment-how-ai-opens-careers-to-young-people"
  ["blog_url"]=>
  string(184) "https://talentculture.com/blog/talent-assessment-how-ai-opens-careers-to-young-people/?utm_source=rss&utm_medium=rss&utm_campaign=talent-assessment-how-ai-opens-careers-to-young-people"
  [15]=>
  string(19) "2024-01-12 23:00:13"
  ["add_date"]=>
  string(19) "2024-01-12 23:00:13"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:52"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:52"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9191"
  ["article_id"]=>
  string(4) "9191"
  [1]=>
  string(50) "Contract packaging predicted to see growth in 2024"
  ["article_title"]=>
  string(50) "Contract packaging predicted to see growth in 2024"
  [2]=>
  string(163) "The outlook for pharma services in 2024 is continuing to improve, with 94% of the industry either ‘moderately positive’ (37%) or ‘highly positiv"
  ["short_description"]=>
  string(163) "The outlook for pharma services in 2024 is continuing to improve, with 94% of the industry either ‘moderately positive’ (37%) or ‘highly positiv"
  [3]=>
  string(220) "The outlook for pharma services in 2024 is continuing to improve, with 94% of the industry either ‘moderately positive’ (37%) or ‘highly positive’ (37%) on growth for contract packaging in 2024."
  ["description"]=>
  string(220) "The outlook for pharma services in 2024 is continuing to improve, with 94% of the industry either ‘moderately positive’ (37%) or ‘highly positive’ (37%) on growth for contract packaging in 2024."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(121) "https://www.medicalplasticsnews.com/news/latest-medical-plastics-news/contract-packaging-predicted-to-see-growth-in-2024/"
  ["blog_url"]=>
  string(121) "https://www.medicalplasticsnews.com/news/latest-medical-plastics-news/contract-packaging-predicted-to-see-growth-in-2024/"
  [15]=>
  string(19) "2024-01-12 19:31:55"
  ["add_date"]=>
  string(19) "2024-01-12 19:31:55"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:42"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:42"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9192"
  ["article_id"]=>
  string(4) "9192"
  [1]=>
  string(59) "BD to showcase prefillable syringes portfolio at Pharmapack"
  ["article_title"]=>
  string(59) "BD to showcase prefillable syringes portfolio at Pharmapack"
  [2]=>
  string(150) "BD, a global medical technology company, will showcase numerous drug delivery innovations at Pharmapack 2024, which will take place 24-25 January in P"
  ["short_description"]=>
  string(150) "BD, a global medical technology company, will showcase numerous drug delivery innovations at Pharmapack 2024, which will take place 24-25 January in P"
  [3]=>
  string(155) "BD, a global medical technology company, will showcase numerous drug delivery innovations at Pharmapack 2024, which will take place 24-25 January in Paris."
  ["description"]=>
  string(155) "BD, a global medical technology company, will showcase numerous drug delivery innovations at Pharmapack 2024, which will take place 24-25 January in Paris."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "41"
  ["rss_id"]=>
  string(2) "41"
  [14]=>
  string(109) "https://www.medicalplasticsnews.com/news/latest-medical-plastics-news/bd-to-host-learning-labs-at-pharmapack/"
  ["blog_url"]=>
  string(109) "https://www.medicalplasticsnews.com/news/latest-medical-plastics-news/bd-to-host-learning-labs-at-pharmapack/"
  [15]=>
  string(19) "2024-01-12 18:03:18"
  ["add_date"]=>
  string(19) "2024-01-12 18:03:18"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:42"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:42"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9234"
  ["article_id"]=>
  string(4) "9234"
  [1]=>
  string(51) "Australia's digital health pipeline in 10 years"
  ["article_title"]=>
  string(51) "Australia's digital health pipeline in 10 years"
  [2]=>
  string(137) "The government is doubling down on modernising My Health Record and building a framework for national health information sharing. &#nl"
  ["short_description"]=>
  string(137) "The government is doubling down on modernising My Health Record and building a framework for national health information sharing. &#nl"
  [3]=>
  string(137) "The government is doubling down on modernising My Health Record and building a framework for national health information sharing. &#nl"
  ["description"]=>
  string(137) "The government is doubling down on modernising My Health Record and building a framework for national health information sharing. &#nl"
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "57"
  ["rss_id"]=>
  string(2) "57"
  [14]=>
  string(85) "https://www.healthcareitnews.com/news/anz/australias-digital-health-pipeline-10-years"
  ["blog_url"]=>
  string(85) "https://www.healthcareitnews.com/news/anz/australias-digital-health-pipeline-10-years"
  [15]=>
  string(19) "2024-01-12 16:26:50"
  ["add_date"]=>
  string(19) "2024-01-12 16:26:50"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:20:53"
  ["create_at"]=>
  string(19) "2024-01-23 20:20:53"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9131"
  ["article_id"]=>
  string(4) "9131"
  [1]=>
  string(82) "FDA Allows Importation of Penicillin From France to Address Syphilis Drug Shortage"
  ["article_title"]=>
  string(82) "FDA Allows Importation of Penicillin From France to Address Syphilis Drug Shortage"
  [2]=>
  string(153) "&#nl        To address the ongoing U.S. shortages of Bicillin L-A, a drug used to treat syphilis, the FDA has temporarily approved French manufacturer La"
  ["short_description"]=>
  string(153) "&#nl        To address the ongoing U.S. shortages of Bicillin L-A, a drug used to treat syphilis, the FDA has temporarily approved French manufacturer La"
  [3]=>
  string(321) "&#nl        To address the ongoing U.S. shortages of Bicillin L-A, a drug used to treat syphilis, the FDA has temporarily approved French manufacturer Laboratoires Delbert to import 3.6 million units of Extencilline, (benzathine benzylpenicillin) a drug not approved by the FDA, but also used to treat syphilis.&#nl      "
  ["description"]=>
  string(321) "&#nl        To address the ongoing U.S. shortages of Bicillin L-A, a drug used to treat syphilis, the FDA has temporarily approved French manufacturer Laboratoires Delbert to import 3.6 million units of Extencilline, (benzathine benzylpenicillin) a drug not approved by the FDA, but also used to treat syphilis.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(122) "https://www.fdanews.com/articles/213111-fda-allows-importation-of-penicillin-from-france-to-address-syphilis-drug-shortage"
  ["blog_url"]=>
  string(122) "https://www.fdanews.com/articles/213111-fda-allows-importation-of-penicillin-from-france-to-address-syphilis-drug-shortage"
  [15]=>
  string(19) "2024-01-12 03:55:49"
  ["add_date"]=>
  string(19) "2024-01-12 03:55:49"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:51"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:51"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9132"
  ["article_id"]=>
  string(4) "9132"
  [1]=>
  string(80) "Two Guidances Focus on ANDA Reconsideration and Viral Safety of Biotech Products"
  ["article_title"]=>
  string(80) "Two Guidances Focus on ANDA Reconsideration and Viral Safety of Biotech Products"
  [2]=>
  string(153) "&#nl        In two recently issued documents, the FDA tackled methods for requesting reconsideration of an ANDA decision and provided final guidance on e"
  ["short_description"]=>
  string(153) "&#nl        In two recently issued documents, the FDA tackled methods for requesting reconsideration of an ANDA decision and provided final guidance on e"
  [3]=>
  string(216) "&#nl        In two recently issued documents, the FDA tackled methods for requesting reconsideration of an ANDA decision and provided final guidance on evaluating the viral safety of biotechnology products.&#nl      "
  ["description"]=>
  string(216) "&#nl        In two recently issued documents, the FDA tackled methods for requesting reconsideration of an ANDA decision and provided final guidance on evaluating the viral safety of biotechnology products.&#nl      "
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "16"
  ["rss_id"]=>
  string(2) "16"
  [14]=>
  string(120) "https://www.fdanews.com/articles/213110-two-guidances-focus-on-anda-reconsideration-and-viral-safety-of-biotech-products"
  ["blog_url"]=>
  string(120) "https://www.fdanews.com/articles/213110-two-guidances-focus-on-anda-reconsideration-and-viral-safety-of-biotech-products"
  [15]=>
  string(19) "2024-01-12 03:30:38"
  ["add_date"]=>
  string(19) "2024-01-12 03:30:38"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:51"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:51"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}
                    

array(40) {
  [0]=>
  string(4) "9091"
  ["article_id"]=>
  string(4) "9091"
  [1]=>
  string(89) "Bayer’s AskBio initiates Phase II GenePHIT trial in Congestive Heart Failure (CHF)"
  ["article_title"]=>
  string(89) "Bayer’s AskBio initiates Phase II GenePHIT trial in Congestive Heart Failure (CHF)"
  [2]=>
  string(150) "Berlin, Germany/Research Triangle Park, North Carolina, USA, January 11, 2024 – Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene "
  ["short_description"]=>
  string(150) "Berlin, Germany/Research Triangle Park, North Carolina, USA, January 11, 2024 – Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene "
  [3]=>
  string(252) "Berlin, Germany/Research Triangle Park, North Carolina, USA, January 11, 2024 – Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, have announced..."
  ["description"]=>
  string(252) "Berlin, Germany/Research Triangle Park, North Carolina, USA, January 11, 2024 – Bayer AG and Asklepios BioPharmaceutical, Inc. (AskBio), a gene therapy company wholly owned and independently operated as a subsidiary of Bayer AG, have announced..."
  [4]=>
  NULL
  ["image"]=>
  NULL
  [5]=>
  NULL
  ["big_image"]=>
  NULL
  [6]=>
  NULL
  ["feature_images"]=>
  NULL
  [7]=>
  NULL
  ["employer_id"]=>
  NULL
  [8]=>
  string(1) "1"
  ["category"]=>
  string(1) "1"
  [9]=>
  string(3) "RSS"
  ["added_by"]=>
  string(3) "RSS"
  [10]=>
  string(2) "10"
  ["status"]=>
  string(2) "10"
  [11]=>
  NULL
  ["highlight_status"]=>
  NULL
  [12]=>
  NULL
  ["hit_count"]=>
  NULL
  [13]=>
  string(2) "15"
  ["rss_id"]=>
  string(2) "15"
  [14]=>
  string(126) "https://www.drugs.com/clinical_trials/bayer-s-askbio-initiates-phase-ii-genephit-trial-congestive-heart-failure-chf-21273.html"
  ["blog_url"]=>
  string(126) "https://www.drugs.com/clinical_trials/bayer-s-askbio-initiates-phase-ii-genephit-trial-congestive-heart-failure-chf-21273.html"
  [15]=>
  string(19) "2024-01-12 03:01:33"
  ["add_date"]=>
  string(19) "2024-01-12 03:01:33"
  [16]=>
  NULL
  ["bythe"]=>
  NULL
  [17]=>
  NULL
  ["timestamp"]=>
  NULL
  [18]=>
  string(19) "2024-01-23 20:19:50"
  ["create_at"]=>
  string(19) "2024-01-23 20:19:50"
  [19]=>
  string(0) ""
  ["slug"]=>
  string(0) ""
}